-+ 0.00%
-+ 0.00%
-+ 0.00%

The US Food and Drug Administration granted BeiGene's Brukinsa priority review for mantle cell lymphoma.

Zhitongcaijing·11/04/2026 14:17:25
Listen to the news
The US Food and Drug Administration granted BeiGene's Brukinsa priority review for mantle cell lymphoma.